CVS Health ( (CVS)) just unveiled an update. On April 7, 2025, CVS Health announced key leadership changes effective in May 2025. Brian O. Newman was appointed as the Executive Vice President and ...

Diversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.

Glenview said Friday that CVS needed to make changes to both leadership and the board. “We believe the Company’s culture, governance and leadership should be strengthened by those with both ...

No decision is imminent and it's possible there won't be changes to CVS' business ... "Glenview and CVS Leadership are engaged in good faith and constructive conversations through which Glenview ...

CVS) came as new CEO David Joyner revealed significant leadership changes meant to revive the healthcare behemoth. Though a 6.3% revenue increase to $95.43 billion above the $92.72 billion ...

"The new leadership announcement gives us hope that CVS is moving quickly to improve ... Having said that, we will be watching closely what changes management will make and how those changes ...

Dr. Creagh Milford will continue to be interim president of retail health at CVS Health until the company finds a replacement ...

The latest appointments come as CVS has made a number of recent leadership changes in recent months while it navigates a challenging financial environment. The company’s profits were nearly cut ...

"The new leadership announcement gives us hope that CVS is moving quickly to improve ... Having said that, we will be watching closely what changes management will make and how those changes ...

"We are taking action today to ensure we make the most of our many opportunities, including leadership changes in the Health Care Benefits segment." CVS will also tap Katerina Guerraz, its ...

CVS Health CEO Karen Lynch has stepped down ... Leerink Partners analyst Michael Cherny said the leadership change was unexpected, though he understood the rationale behind it “following another ...

which are down 24% in a year of record highs for the broader market and are nearly half of CVS's 2022 highs. Andrew Mok, a senior analyst at Barclays, said a leadership change "was largely ...